Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: rosuvastatin
Sponsor: Beth Israel Deaconess Medical Center
Collaborators: Dana-Farber Cancer Institute|Massachusetts General Hospital|National Institutes of Health (NIH)